Curi RMB Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,287
| Closed | -$1.17M | – | 473 |
|
|
2021
Q1 | $1.17M | Sell |
10,287
-18,402
| -64% | -$2.09M | 0.04% | 243 |
|
|
2020
Q4 | $3.97M | Buy |
28,689
+546
| +2% | +$75.6K | 0.15% | 146 |
|
|
2020
Q3 | $2.31M | Buy |
28,143
+1,459
| +5% | +$120K | 0.1% | 178 |
|
|
2020
Q2 | $2.09M | Sell |
26,684
-3,070
| -10% | -$240K | 0.09% | 196 |
|
|
2020
Q1 | $1.32M | Buy |
29,754
+476
| +2% | +$21.1K | 0.06% | 240 |
|
|
2019
Q4 | $1.25M | Sell |
29,278
-558
| -2% | -$23.8K | 0.03% | 322 |
|
|
2019
Q3 | $1.28M | Buy |
29,836
+3,033
| +11% | +$130K | 0.03% | 338 |
|
|
2019
Q2 | $1.7M | Buy |
26,803
+1,774
| +7% | +$113K | 0.04% | 312 |
|
|
2019
Q1 | $1.74M | Hold |
25,029
| – | – | 0.04% | 342 |
|
|
2018
Q4 | $1.09M | Sell |
25,029
-811
| -3% | -$35.3K | 0.03% | 454 |
|
|
2018
Q3 | $1.97M | Sell |
25,840
-2,513
| -9% | -$192K | 0.05% | 355 |
|
|
2018
Q2 | $2.18M | Sell |
28,353
-16,825
| -37% | -$1.29M | 0.05% | 334 |
|
|
2018
Q1 | $2.3M | Buy |
45,178
+1,445
| +3% | +$73.7K | 0.06% | 334 |
|
|
2017
Q4 | $2.03M | Sell |
43,733
-4,162
| -9% | -$193K | 0.05% | 353 |
|
|
2017
Q3 | $2.55M | Buy |
47,895
+8,470
| +21% | +$451K | 0.07% | 305 |
|
|
2017
Q2 | $2.45M | Buy |
+39,425
| New | +$2.45M | 0.07% | 312 |
|